The Harvard Drug Group LLC recalls Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJ…
- Recall date
- June 19, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0507-2025
- FDA classification
- Class II
- Brand / firm
- The Harvard Drug Group LLC
- Sold / distributed
- Nationwide
Why it was recalled
Defective container; blister packaging inadequately sealed.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61
Get recall alerts
Free email alert whenever The Harvard Drug Group LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: The Harvard Drug Group LLC